Oculis Announces Patient Dosing in its First Phase 3 (DIAMOND Study - DIAbetic Macular edema patients ON a Drop) with OCS-01, a Novel, Investigational Topical Eye Drop Treatment for Diabetic Macular Edema (DME)

OCS-01 is a novel, high concentration, preservative free, topical formulation of dexamethasone (DSNP) that has the potential to be the first topical eye drop and non-invasive treatment for DME.